The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction

Background The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE) and the A1166C polymorphism of the angiotensin-II AT1 receptor (AT1R) have been extensively investigated as possible risk factors for myocardial infarction (MI). Design and methods Genetic association, case-control study, specifically designed to investigate the association of the above-mentioned polymorphisms with risk of MI in a homogeneous, low coronary risk, Caucasian population. The study population consisted of 1603 consecutive patients with acute MI who were recruited from nine clinics, located in three cities, and 699 unrelated adults who were randomly selected from the city catalogues. Results In univariate analysis, the DD genotype was found to be more prevalent among controls (40.8 vs. 35.2%, P = 0.011). In multivariate analysis adjusted for age, gender, smoking status, diabetes mellitus, hypercholesterolemia, hypertension and family history of coronary artery disease, the presence of the DD genotype was independently and negatively associated with risk of AMI (RR = 0.743, 95% CI = 0.595–0.927, P = 0.008). The CC genotype was not found to be significantly associated with risk of MI, either in univariate (6.2 vs. 6.4%, P = 0.856), or in multivariate analysis adjusted for the same confounders (RR = 0.743, 95% CI = 0.473–1.167, P = 0.197). Conclusions Contrary to previous reports, in this study the DD genotype of the ACE gene, but not the CC genotype of the AT1R gene, was associated with a lower risk of MI. Our results emphasize the complexity of genotype-phenotype interactions in the pathogenesis of ischaemic heart disease and question the previously hypothesized role of the DD genotype on risk of acute myocardial infarction.

[1]  Christodoulos Stefanadis,et al.  Risk stratification of coronary heart disease in Greece: final results from the CARDIO2000 Epidemiological Study. , 2002, Preventive medicine.

[2]  Y. Bossé,et al.  Influence of the angiotensin‐converting enzyme gene insertion/deletion polymorphism on lipoprotein/lipid response to gemfibrozil , 2002, Clinical genetics.

[3]  P Toutouzas,et al.  Risk Stratification of Coronary Heart Disease Through Established and Emerging Lifestyle Factors in a Mediterranean Population: CARDIO2000 Epidemiological Study , 2001, Journal of cardiovascular risk.

[4]  P. Toutouzas,et al.  In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study. , 2001, European heart journal.

[5]  David R. Wood,et al.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.

[6]  K. Kohara,et al.  Association of ACE I/D polymorphism with cardiovascular risk factors , 2000, Human Genetics.

[7]  R. Abbate,et al.  Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. , 2000, European heart journal.

[8]  Sarah Parish,et al.  Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls , 1999, The Lancet.

[9]  A. Gotto,et al.  Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. , 2000, Journal of the American College of Cardiology.

[10]  R. Gershoni-baruch,et al.  The D allele of the angiotensin-converting enzyme gene contributes towards blood LDL-cholesterol levels and the presence of hypertension. , 1999, Atherosclerosis.

[11]  A. Gardemann,et al.  Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. , 1998, European heart journal.

[12]  J. Staessen,et al.  Genetic Variability in the Renin-Angiotensin System: Prevalence of Alleles and Genotypes , 1997, Journal of cardiovascular risk.

[13]  D Kromhout,et al.  Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe , 1997 .

[14]  A. Morice,et al.  Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. , 1996, Journal of the American College of Cardiology.

[15]  Y. Yazaki,et al.  Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. , 1996, Coronary artery disease.

[16]  D. Wilcken,et al.  Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[17]  T. Wienker,et al.  An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men. , 1995, The American journal of cardiology.

[18]  A. Marian,et al.  Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[19]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[20]  P Ducimetière,et al.  Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction , 1994, The Lancet.

[21]  G. Sagnella,et al.  Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin , 1994, Journal of hypertension.

[22]  J. Erikssen,et al.  Insertion/deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and myocardial infarction , 1993, Clinical genetics.

[23]  Philippe Amouyel,et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.

[24]  F. Soubrier,et al.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.

[25]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[26]  S. Nanas,et al.  Coronary heart disease risk factors in a random sample of Athenian adults. The Athens Study. , 1987, American journal of epidemiology.